Charles River Laboratories International Investors
Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Founded Date:
1947-01-01
Technology:
Drug Delivery
Funding Status:
IPO
Total Funding:
1534000000.0
Employee Number:
5001-10000
Headquarters:
Wilmington, Massachusetts, United States
Last Funding Date:
2021-03-23
Investors Number:
1.0
Last Funding Type:
Post-IPO Debt
Estimated Revenue:
$500M to $1B
Acquisitions Number:
32
Number Of Exists:
1
Industry:
Early Drug Development